GLP-1 receptor agonists (including medications like semaglutide, liraglutide, and tripeptide) mimic the action of this natural hormone
Activated NKT cells use Gln to provide fuel for the TCA cycle and GLULH synthesis, thereby increasing the proliferation capacity of NK cells
von Moos R, Thuerlimann BJ, Aapro M, Rayson D, Harrold K, Sehouli J, et al
INGREDIENTS Purified water, L-carnitine tartrate, fructose, acidity regulator (sodium hydroxide), emulsifier (polysorbate 20 and phosphatidylcholine), flavour (lemon flavour), preservative (potassium sorbate) and sweetener (sucralose)
The two companies had referred to PF-07081532 as the next-generation GLP-1 agonist, an oral once-daily treatment to be tested for type 2 diabetes and obesity
Cleveland Clinic Study (2025)